Clinical Outcome Assessments To Be Developed Under US FDA Grants

The projects could help streamline rare disease drug development, along with the Rare Disease Cures Accelerator.

Abstract mash line and point magnifying glass on white background with an inscription. Starry sky or space, consisting of stars and the universe. Vector business illustration
The core clinical outcome measures would be publicly available for little or no cost. • Source: Shutterstock

More from Clinical Trials

More from R&D